Skip to main content

Table 5 Association between patient characteristics and moderate to severe conjunctival hyperemia (grade 2 and 3) in univariate logistic regression models

From: Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China

 

OR

95% CI

P-value

Age, years

1.338

0.627- 2.856

0.4521

(≥ 50 vs < 50)

Diagnosis

1.624

0.541- 4.877

0.3871

(POAG vs OHT)

Sex

2.178

0.935-5.072

0.0711

(male vs female)

History of laser treatment for glaucoma

0.289

0.038-2.214

0.2321

(yes vs no)

History of surgical treatment for glaucoma

0.882

0.342-2.275

0.7956

(yes vs no)

Comorbidities

1.346

0.479-3.783

0.5725

(yes vs no)

Hypertension

0.663

0.293-1.500

0.3237

(yes vs no)

Duration of pre-study antiglaucoma medication use

1.257

0.592-2.668

0.5516

(< 1 month vs ≥ 1 month )

   
  1. OR odds ratio; CI confidential interval.